Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Esserman

Showing results (181-190 of 308) with videos related to

Pageof 31
Sort By:
NPJ Breast Cancer|June 18, 2021
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trialHolly Keane, Yash S Huilgol, Yiwey Shieh, et al.
NPJ Breast Cancer|September 14, 2018
Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancerMark Jesus M Magbanua, Hope S Rugo, Louai Hauranieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Magnetic resonance imaging captures the biology of ductal carcinoma in situLaura J Esserman, Anjali S Kumar, Alex F Herrera, et al.
Journal of Digital Imaging|April 22, 2021
Mask-Guided Convolutional Neural Network for Breast Tumor Prognostic Outcome Prediction on 3D DCE-MR ImagesGengbo Liu, Debasis Mitra, Ella F Jones, et al.
International Journal of Cancer|October 25, 2025
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trialOscar Danielsson, Huma Dar, Gizeh Perez-Tenorio, et al.
The Lancet. Oncology|May 9, 2014
Addressing overdiagnosis and overtreatment in cancer: a prescription for changeLaura J Esserman, Ian M Thompson, Brian Reid, et al.
Communications Medicine|October 30, 2025
Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trialAli B Abbasi, Kathleen D Liu, Derek W Russell, et al.
Breast Cancer Research and Treatment|September 6, 2011
Impact of mammographic screening on the detection of good and poor prognosis breast cancersLaura J Esserman, Yiwey Shieh, Emiel J T Rutgers, et al.
Communications Medicine|March 24, 2026
Author Correction: Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trialAli B Abbasi, Kathleen D Liu, Derek W Russell, et al.
The Lancet. Oncology|June 21, 2011
Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen typesSherene Loi, W Fraser Symmans, John M S Bartlett, et al.
Pageof 31

Showing results (181-190 of 308) with videos related to

Sort By:
Pageof 31
NPJ Breast Cancer|June 18, 2021
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trialHolly Keane, Yash S Huilgol, Yiwey Shieh, et al.
NPJ Breast Cancer|September 14, 2018
Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancerMark Jesus M Magbanua, Hope S Rugo, Louai Hauranieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Magnetic resonance imaging captures the biology of ductal carcinoma in situLaura J Esserman, Anjali S Kumar, Alex F Herrera, et al.
Journal of Digital Imaging|April 22, 2021
Mask-Guided Convolutional Neural Network for Breast Tumor Prognostic Outcome Prediction on 3D DCE-MR ImagesGengbo Liu, Debasis Mitra, Ella F Jones, et al.
International Journal of Cancer|October 25, 2025
Progesterone receptor (PR) intra-tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trialOscar Danielsson, Huma Dar, Gizeh Perez-Tenorio, et al.
The Lancet. Oncology|May 9, 2014
Addressing overdiagnosis and overtreatment in cancer: a prescription for changeLaura J Esserman, Ian M Thompson, Brian Reid, et al.
Communications Medicine|October 30, 2025
Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trialAli B Abbasi, Kathleen D Liu, Derek W Russell, et al.
Breast Cancer Research and Treatment|September 6, 2011
Impact of mammographic screening on the detection of good and poor prognosis breast cancersLaura J Esserman, Yiwey Shieh, Emiel J T Rutgers, et al.
Communications Medicine|March 24, 2026
Author Correction: Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trialAli B Abbasi, Kathleen D Liu, Derek W Russell, et al.
The Lancet. Oncology|June 21, 2011
Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen typesSherene Loi, W Fraser Symmans, John M S Bartlett, et al.
Pageof 31